In Tasmania, the most common cancer diagnosed in males is prostate cancer, with a reported incidence of 446 in 2012 (Fig 1). Of the 446 men diagnosed in Tasmania, 72 men died as a direct result of prostate cancer (Tasmanian Cancer Registry. (2012). Incidence and Mortality 2012. Hobart, Tasmania: www.menzies.utas.edu.au/cancer_reg.html).
PCOR-TAS is one registry that contributes data into the Prostate Cancer Outcomes Registry - Australia and New Zealand (PCOR-ANZ). PCOR-ANZ is an international initiative funded by Movember Foundation, and lead by a team at Monash University School of Public Health and Preventive Medicine.
Collectively the PCOR-ANZ will provide data regarding diagnosis, treatment and long term quality outcomes to help identify whether there are trends or gaps that exist in service provision across Australia and New Zealand.
The aims of PCOR-TAS are to:
- Assess patterns of care
- Reduce variation in treatments and outcomes
- Improve compliance with best practice-based guidelines for the treatment of prostate cancer
- Provide information to assist in the credentialing of clinicians and identification of appropriate training resources
- Identify factors that predict favourable and unfavourable treatment outcomes, particularly in relation to the major adverse effects
- Provide information to patients about the risks and benefits of specific approaches to prostate cancer treatment
- Support research into prostate cancer at a population level
Other jusisdictions participating in PCOR-ANZ include
For more information regarding PCOR-ANZ, please visit the PCOR-ANZ website.